A Systematic Review and Meta-Analysis of Studies of Defibrotide Prophylaxis for Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Selim CorbaciogluOzlem TopalogluSaurabh Aggarwal Systematic Review Open access 20 May 2022 Pages: 465 - 476
Re-Routing Infliximab Therapy: Subcutaneous Infliximab Opens a Path Towards Greater Convenience and Clinical Benefit Rieke AltenYoorim AnLaurent Peyrin-Biroulet Review Article 03 June 2022 Pages: 477 - 489
Cost-Effectiveness Analysis of Atezolizumab Versus Durvalumab as First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer in the USA Yelena IonovaWilson VuongLeslie Wilson Original Research Article Open access 23 May 2022 Pages: 491 - 500
Cost Effectiveness of Dapagliflozin Added to Standard of Care for the Management of Diabetic Nephropathy in the USA Tadesse M. AbegazVakaramoko DiabyAskal Ayalew Ali Original Research Article 25 May 2022 Pages: 501 - 511
A Phase 1, Open-Label Study to Evaluate the Effects of Food and Evening Dosing on the Pharmacokinetics of Oral Trofinetide in Healthy Adult Subjects Mona DarwishJames M. YouakimSerge Stankovic Original Research Article Open access 27 May 2022 Pages: 513 - 524
Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection Matteo MegnaCataldo PatrunoGabriella Fabbrocini Original Research Article Open access 28 May 2022 Pages: 525 - 531
Impact of Sacubitril/Valsartan on Lipid Parameters in Patients with Heart Failure with Reduced Ejection Fraction Hasan Ali BarmanSelim TanyolaçZerrin Yiğit Original Research Article 30 May 2022 Pages: 533 - 540
Rare Mycobacteria and HIV in Children: Two Case Reports Sarah M. JohnsonCecilia PiñeraCaroline Foster Research Letter 16 May 2022 Pages: 541 - 547